PrecisCa
Avatar

Breast Tumor Board Case Discussion: 27 y/o Female With Stage IV pT3N1M1a IDC of the Left Breast With Bilateral Biopsy Proven Axillary Involvement

By PrecisCa FEATURING William Gradishar, Sara A. Hurvitz, Norman Wolmark, Reni Butler, Thomas Buchholz
August 25, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
27:39
Breast Health Global Initiative

Metastatic Breast Disease: Treatment and Palliative Care

Feat. A. Eniu
14:37
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 2: Patient with…

Feat. J. Abraham
30:13
Nico Karssemeijer

Deep Learning Systems for Reading Mammograms and Breast Tomosynthesis

19:43
Northwestern Medicine: Chicago Live

Northwestern Live: Live Case - 47 y/o Female with History of Metasta…

Feat. D. Mullady, A. Aadam
19:23
Holy Cross 9th Annual Winter Oncology Symposium

Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhib…

Feat. D. Guaqueta
13:07
Holy Cross 9th Annual Winter Oncology Symposium

Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…

Feat. E. Segota, R. L. Mahtani, J. Burgers, M. Abu-Khalaf, B. Moy
07:43
Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Feat. S. Goel
24:33
Holy Cross 9th Annual Winter Oncology Symposium

Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…

Feat. B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium

Future Directions in the Targeting of HER2+ Breast Cancer: duration …

Feat. B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…

Feat. M. Abu-Khalaf
07:58
Sandra Swain

ASCO 2019 End-of-study Survival Analysis from the Cleopatra Study Sh…

19:29
2019 Scripps MD Anderson's Oncology Update

ASCO Metastatic HER2+ Breast Review: How Long to Treat Is up To Deba…

Feat. J. Mortimer
18:38
Peter Schmid

Immunotherapy in Metastatic Triple Negative Breast Cancer: IMpassion…

07:23
Dana-Farber Cancer Institute

Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer

Feat. S. Tolaney
07:40
Dana-Farber Cancer Institute

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Br…

Feat. S. Tolaney
13:18
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Case of a 65 y/o Woman with DCIS Breast Cancer, pN1 Micrometastases …

Feat. S. Modi, H. Jacene, F. Vicini, H. Rugo
14:20
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Case of a 35 y/o Woman with Micrometastatic Carcinoma, RCB-II Whose …

Feat. S. Modi, H. Jacene, F. Vicini, H. Rugo
05:52
Ashley Mathews

PD-L1 Testing in Breast Cancer: What Makes a Breast Cancer Patient E…

14:11
UNC Lineberger Comprehensive Cancer Center

UNC's 2019 ASCO Update on Margetuximab + Chemo vs Trastuzumab v…

Feat. E. Ray
16:31
Sandra Swain

Firstline Treatment for HER2+ Metastatic Breast Cancer: How HER2-Tar…